Genovis acquires KPL to expand enzyme platform
The acquisition adds KPL's proprietary precision proteases for mass spectrometry-based protein analysis, strengthening Genovis' coverage in proteomics.
See the latest news and media coverage for Genovis. We track all announcements, press releases, and industry mentions in real time, all in one place.
Biotechnology company specializing in protein analysis tools
genovis.comLast updated
In short: Genovis expanded its genomics and proteomics platforms through key acquisitions and partnerships while maintaining steady sales growth.
The acquisition adds KPL's proprietary precision proteases for mass spectrometry-based protein analysis, strengthening Genovis' coverage in proteomics.
The meeting approved financial statements, re-elected board, authorized share issuance, and updated remuneration guidelines.
Net sales reached SEK 33,506 thousand. EBITDA improved to SEK 9,510 thousand. Launched LysCERATOR™ and SEQguard™. Signed ADC license deal.
The meeting occurs on May 18, 2026, at 5:00 p.m. in Kävlinge. Proposals cover board elections, fees, auditors, remuneration guidelines, and share issue authorizations.
kr 20.95 SEK-0.05-0.24% ...
Genovis AB announces that Chief Financial Officer (CFO) Magnus Långberg has decided to leave the company to pursue a new opportunity outside the Group. Magnus...
Genovis' innovative products and technologies are used by scientists all over the world and the product formats streamline and improve workflows in biochemical analysis and...
Plasmidsaurus, the leading Sequencing as a Service company, has announced two transformative evolutions of its RNA-Seq ecosystem: the launch of a high-capacity RNA sequencing hub...
Track Genovis and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Genovis and other trending companies.